Lumena Pharmaceuticals' Series B Round

Lumena Pharmaceuticals raised a round of funding on March 11, 2014.

Lumena Pharmaceuticals is developing oral therapeutics for rare liver diseases to improve liver function, relieve disease symptoms and dramatically impact patient health. The company's clinical-stage …

Articles about Lumena Pharmaceuticals' Series B Round: